Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL |
Temple University / Christian Hurtz, PhD |
'A' Award Grants |
2022 |
Pennsylvania |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes |
Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD |
'A' Award Grants |
2021 |
Massachusetts |
A Cell Morphology Landscape of Pediatric Cancer Cell Lines |
University of Colorado Denver_ Anschutz Medical Campus / Gregory Way, PhD |
'A' Award Grants |
2023 |
Colorado |
Unraveling the Function of PAX3-FOXO1’s Activation Domain in Rhabdomyosarcoma |
Case Western Reserve University / Berkley Gryder, PhD |
'A' Award Grants |
2023 |
Ohio |
Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Kyle MacQuarrie, MD/PhD |
'A' Award Grants |
2023 |
Illinois |
Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML |
Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD |
'A' Award Grants |
2012 |
Washington |
Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting |
St. Jude Children’s Research Hospital / Stephen Mack, PhD |
'A' Award Grants |
2018 |
Tennessee |
Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia |
Washington University / Grant Challen, PhD |
'A' Award Grants |
2012 |
Missouri |